Literature DB >> 2867389

Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone.

J Adams, S Franks, D W Polson, H D Mason, N Abdulwahid, M Tucker, D V Morris, J Price, H S Jacobs.   

Abstract

By means of pelvic ultrasonography, a multifollicular ovarian appearance was observed in women with weight-loss-related amenorrhoea. Multifollicular ovaries (MFO) are normal in size or slightly enlarged and filled by six or more cysts 4-10 mm in diameter; in contrast to women with polycystic ovaries (PCO), stroma is not increased. Unlike PCO patients, women with MFO were not hirsute and serum concentrations of luteinising hormone and follicle stimulating hormone were normal and decreased, respectively. The uterus was small indicating oestrogen deficiency. In MFO, treatment with gonadotropin releasing hormone (LHRH) induced ovulation in 83% of cycles and there were seven pregnancies in 8 women; in PCO, only 40% of cycles were ovulatory and there were eleven pregnancies (8 women) but six of these aborted. In MFO ovarian morphology reverted to normal in ovulatory cycles, whereas in PCO the polycystic pattern persisted despite the presence of a dominant follicle. MFO may represent a normal ovarian response to weight-related hypothalamic disturbance of gonadotropin control.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2867389     DOI: 10.1016/s0140-6736(85)92552-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  69 in total

1.  Distribution of adiponectin multimeric forms in Chinese women with polycystic ovary syndrome and their relation to insulin resistance.

Authors:  Tao Tao; Edmond P Wickham; Wuqiang Fan; Jiejin Yang; Wei Liu
Journal:  Eur J Endocrinol       Date:  2010-06-07       Impact factor: 6.664

Review 2.  [Pulsatile therapy with LHRH].

Authors:  M H Birkhäuser
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

3.  Polycystic ovaries and polycystic ovary syndrome in epilepsy: evidence for neurogonadal disease.

Authors:  Cynthia L Harden
Journal:  Epilepsy Curr       Date:  2005 Jul-Aug       Impact factor: 7.500

4.  Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure.

Authors:  E S Barrett; K M Hoeger; S Sathyanarayana; D H Abbott; J B Redmon; R H N Nguyen; S H Swan
Journal:  J Dev Orig Health Dis       Date:  2018-01-09       Impact factor: 2.401

Review 5.  Computerized detection and recognition of follicles in ovarian ultrasound images: a review.

Authors:  Božidar Potočnik; Boris Cigale; Damjan Zazula
Journal:  Med Biol Eng Comput       Date:  2012-09-26       Impact factor: 2.602

6.  The association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene with the metabolic characteristics in Chinese women with polycystic ovary syndrome.

Authors:  Jiejin Yang; Hao Gong; Wei Liu; Tao Tao
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

7.  A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program.

Authors:  N O Turhan; P G Artini; G D'Ambrogio; F Droghini; C Battaglia; A D Genazzani; A Volpe; A R Genazzani
Journal:  J Assist Reprod Genet       Date:  1993-01       Impact factor: 3.412

8.  Prenatal exposure to stressful life events is associated with masculinized anogenital distance (AGD) in female infants.

Authors:  Emily S Barrett; Lauren E Parlett; Sheela Sathyanarayana; Fan Liu; J Bruce Redmon; Christina Wang; Shanna H Swan
Journal:  Physiol Behav       Date:  2013-03-13

9.  Prostate specific antigen in women with menstrual disturbances and fibrocystic mastopathy.

Authors:  S Radowicki; M Kunicki
Journal:  J Endocrinol Invest       Date:  2009-07-14       Impact factor: 4.256

10.  Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging.

Authors:  Nike M M L Stikkelbroeck; Ad R M M Hermus; Diana Schouten; Harold M Suliman; Gerrit J Jager; Didi D M Braat; Barto J Otten
Journal:  Eur Radiol       Date:  2004-08-18       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.